Age-Related Macular Degeneration (AMD) is a common eye condition that affects millions worldwide. In fact, research shows, around one in every 200 people has AMD at 60. As we age, the delicate macula, a small area in the centre of the retina, can deteriorate, leading to blurred vision and potential sight loss.
In the past, the progression of AMD was often inevitable. However, recent advancements in medical technology have brought forth innovative treatments, including Valeda Light Therapy. This groundbreaking therapy offers hope to those affected by AMD, providing a non-invasive approach to slow down the disease’s progression and potentially improve vision.
In this blog post, we’ll discuss AMD, explore the impact of this condition on daily life, and uncover the potential benefits of Valeda Light Therapy.
What is Macular Degeneration?
Macular degeneration is a common eye condition where cells in the middle of the retina (the light-sensitive layer at the back of your eye) die or are damaged, making it difficult to see fine details clearly.
The most common form of macular disease is age-related macular degeneration (AMD), which generally affects people over 50. The macula is only 5mm in size but is key for seeing fine details.
There are two types of AMD:
- Dry: This is build-up of waste material
- Wet: Abnormal blood vessels start to grow underneath and leak blood. Around 10-15% convert from dry to wet
What is the impact of AMD?
Gradual progressive loss of vision
As AMD advances, the clarity of your central focus may diminish, resulting in blurred, distorted, or lost vision. This deterioration significantly affects activities like driving, recognising faces, reading, watching TV, and various aspects of daily life.
Difficulty reading, watching TV, and driving
The ability to discern textures and contrasts diminishes, making it challenging to navigate uneven walkways and stairs, thereby increasing the risk of falls.
Impaired depth perception
Difficulty in accurately judging distances poses a risk of accidents and falls.
Sensitivity to changing light levels
Struggling to adapt to varying light conditions and increased sensitivity to glare become noticeable challenges.
Increased dependence on brighter light
Everyday tasks such as reading, cooking, and other activities may require higher light levels due to diminishing visual acuity.
Can macular degeneration can be treated?
The goal is to slow down the macular degeneration and aim to stop progression to wet. The wet kind has approved injections to slow it down, however this is damage limitation and ongoing treatment.
Can you take supplements for macular degeneration?
Whilst supplements may slow it down, we now have the first FDA and CE marked light therapy to slow it down. Why not offer combination therapy ?
What is Valeda Light Therapy?
Light therapy uses different wavelengths of LED light to target cells and stimulate their activity to slow down the degenerative process. Valeda operates by stimulating energy production within the eye’s cells, enhancing their capability to fulfil their roles effectively. The promotion of cellular health is crucial for maintaining optimal eye health.
Patients will typically have a treatment cycle consisting of nine treatments spread over a three to four week period. Treatment cycles are repeated, ideally three times a year to maintain the effect.
Who is suitable for Valeda Light Therapy
Valeda is prescribed for addressing Dry Age-Related Macular Degeneration (AMD). Individuals undergoing treatment should have received a diagnosis of Dry AMD from an eye care professional. Typically, people aged 50 and above are affected by Dry Age-Related Macular Degeneration and would be suitable for the Valeda Light Therapy System. We can assess your suitability at our eye examination where an OCT scan will be required.
Those who are not suitable for Valeda Light Therapy
As a safety measure, individuals who have not undergone testing or have known light exposure reactions should refrain from receiving treatment with Valeda. Similarly, those with a history of light-activated central nervous system disorders, such as epilepsy or where light exposure triggers migraine, are advised against using Valeda.
Additionally, individuals should avoid treatment within 30 days of using any photosensitising medications, including topicals and injectables, without first consulting their eye care professional.
Is there any downtime?
No, this is great thing! There are no drops or drugs required. You can leave straight away!
What is the Valeda Treatment preparation & process
Preparing for your Valeda treatment
Before your Valeda treatment, you’ll need to remove any glasses or contact lenses. Unlike traditional laser or cataract surgeries, there’s no need for eye dilation, making the process quick and convenient.
The Valeda treatment process
The treatment itself is a straightforward, 10-minute procedure guided by an experienced specialist. You’ll be comfortably seated in front of the Valeda Light Delivery System.
Post-treatment and recovery
Following the treatment, you may experience a brief period of photo stress, a temporary visual effect where the cells responsible for perceiving certain colours become fatigued. This is similar to the afterimage you might see after looking at a bright light. However, this effect typically subsides within a few minutes, allowing you to resume your normal activities without interruption.
Treatment schedule
Most patients undergo a series of treatments, spaced out over 3-4 weeks. It’s recommended to schedule treatments no more than once every 24 hours and to make up any missed sessions within the treatment series.
By following these guidelines, you can maximize the benefits of your Valeda treatment and experience improved vision.
What are the results from the Valeda Light Therapy studies?
- Stabilisation of macular degeneration
- Improvement in vision, contrast and reduction of Drusen
- The studies compared treated eye to non-treated eyes
- No harm caused
- Goal is to slow down the progression
What is the cost of Valeda Light Therapy?
The first treatment cycle of 9 session is £1500. Thereafter treatment cycles which are repeat around 4-6 months would be £1350.
This is not covered by private insurance or NHS.
Choose Simon & Safarian for expert Age Related Dry Macular Degeneration treatment
Don’t let AMD dim your vision. Choose Simon & Safarian for expert Age-Related Dry Macular Degeneration treatment. Under the expert care of optometrist Sachin Patel or Anila Mistry we offer FDA and CE-marked Valeda Light Therapy, a non-invasive treatment proven to slow the progression of AMD.
Book your consultation today and take a step towards preserving your vision.
